First Preclinical Imaging of Primary Cartilage Neoplasm and Its Local Recurrence Using 99mTc-NTP 15-5 Radiotracer
暂无分享,去创建一个
Serge Askienazy | Jean Maublant | J. Maublant | N. Moins | J. Chezal | E. Miot-Noirault | D. Heymann | S. Askienazy | F. Gouin | Françoise Redini | Dominique Heymann | Elisabeth Miot-Noirault | Jean-Michel Chezal | Nicole Moins | F. Redini | A. Vidal | François Gouin | Aurélien Vidal | Maryse Rapp | M. Rapp
[1] H. Gelderblom,et al. The clinical approach towards chondrosarcoma. , 2008, The oncologist.
[2] L. Sarry,et al. Early detection and monitoring of cartilage alteration in the experimental meniscectomised guinea pig model of osteoarthritis by 99mTc-NTP 15-5 scintigraphy , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[3] D. Heymann,et al. Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survival , 2006, International journal of cancer.
[4] F. Bertoni,et al. Surgical treatment and outcome of conventional pelvic chondrosarcoma. , 2005, The Journal of bone and joint surgery. British volume.
[5] R. V. Heertum,et al. 18FDG-PET applications for cartilage neoplasms , 2005, Skeletal Radiology.
[6] K. Nakajima,et al. Characterization of cartilaginous tumors with201Tl scintigraphy , 2005, Annals of nuclear medicine.
[7] Francis Y. Lee,et al. Diagnostic value and limitations of fluorine-18 fluorodeoxyglucose positron emission tomography for cartilaginous tumors of bone. , 2004, The Journal of bone and joint surgery. American volume.
[8] P. Choong,et al. The role of thallium-201 and pentavalent dimercaptosuccinic acid for staging cartilaginous tumours , 2004, International seminars in surgical oncology : ISSO.
[9] W. Brenner,et al. FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[10] D. Vanel,et al. Imaging of chondrosarcomas , 2003, Cancer imaging : the official publication of the International Cancer Imaging Society.
[11] D. Heymann,et al. Bone remodelling and tumour grade modifications induced by interactions between bone and swarm rat chondrosarcoma. , 2002, Histology and histopathology.
[12] H. Hendel,et al. Utility of Planar Bone Scintigraphy To Distinguish Benign Osteochondromas from Malignant Chondrosarcomas , 2002, Clinical nuclear medicine.
[13] G. Arsos,et al. Low-grade chondrosarcomas: a difficult target for radionuclide imaging. Case report and review of the literature. , 2002, European journal of radiology.
[14] T. Aigner,et al. Towards a new understanding and classification of chondrogenic neoplasias of the skeleton – biochemistry and cell biology of chondrosarcoma and its variants , 2002, Virchows Archiv.
[15] T. Aigner,et al. Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas , 2002, Cancer.
[16] P. Hogendoorn,et al. Cartilage-forming tumours of bone and soft tissue and their differential diagnosis , 2001 .
[17] J. Madelmont,et al. Synthesis of N-quaternary ammonium [3H] and [99mTc]polyazamacrocycles, potential radiotracers for cartilage imaging , 2000 .
[18] J. Madelmont,et al. Disposition in rats of N-pyridinium-propyl-cyclam, N-triethylammonium-propyl-cyclam, and N-[Triethylammonium]-3-propyl-[15]ane-N5, potential cartilage imaging agents. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[19] H J Mankin,et al. Chondrosarcoma of bone: an assessment of outcome. , 1999, The Journal of bone and joint surgery. American volume.
[20] C. Masciocchi,et al. Diagnostic imaging of malignant cartilage tumors. , 1998, European journal of radiology.
[21] T. Aigner,et al. Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasms. , 1997, The American journal of pathology.
[22] H. Jacobsson,et al. Comparison of technetium-99m-MIBI and technetium-99m-tetrofosmin uptake by musculoskeletal sarcomas. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] R. Hicks. Nuclear medicine techniques provide unique physiologic characterization of suspected and known soft tissue and bone sarcomas. , 1997, Acta orthopaedica Scandinavica. Supplementum.
[24] A. Schepper,et al. Magnetic resonance imaging of cartilaginous tumors: is it useful or necessary? , 1996, Skeletal Radiology.
[25] Hisataka Kobayashi,et al. Diagnostic Value of Tc‐99m (V) DMSA for Chondrogenic Tumors With Positive Tc‐99m HMDP Uptake on Bone Scintigraphy , 1995, Clinical nuclear medicine.
[26] A. Veyre,et al. Disposition and metabolism of acetylcholinesterase reactivators 2PAM-I, TMB4 and R665 in rats submitted to organophosphate poisoning. , 1991, Xenobiotica; the fate of foreign compounds in biological systems.
[27] G. Steiner,et al. Experimental transplantation of the swarm rat chondrosarcoma into bone: Radiological and pathological studies , 1991, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[28] G. Hascall,et al. Ultrastructure of the chondrocytes and extracellular matrix of the Swarm rat chondrosarcoma , 1980, The Anatomical record.
[29] A. Schiller,et al. The biology of human chondrosarcoma. I. Description of the cases, grading, and biochemical analyses. , 1980, The Journal of bone and joint surgery. American volume.
[30] L. Díaz de León,et al. Histological and biochemical studies of a transplantable rat chondrosarcoma. , 1979, Cancer research.
[31] M. Romsdahl,et al. Prognostic factors in chondrosarcoma of bone. A clinicopathologic analysis with emphasis on histologic grading , 1977, Cancer.
[32] T. Oegema,et al. Isolation and characterization of proteoglycans from the swarm rat chondrosarcoma. , 1975, The Journal of biological chemistry.
[33] R. Grimer,et al. Risk factors for survival and local control in chondrosarcoma of bone. , 2002, The Journal of bone and joint surgery. British volume.
[34] F. Mertens,et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone , 2002 .
[35] A. Veyre,et al. Joint scintigraphy in rabbits with 99mtc-N-[3-(triethylammonio)propyl]-15ane-N5, a new radiodiagnostic agent for articular cartilage imaging. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[36] O. Sargin,et al. Tc-99m tetrofosmin imaging in chondrosarcoma. , 2000, Clinical Nuclear Medicine.
[37] S. McCarthy. Histological Typing of Bone Tumours , 1994 .
[38] W. Taylor,et al. Chondrosarcoma: A clinicopathologic and statistical analysis , 1980, Cancer.
[39] L. J. Roth,et al. Distribution of hexamethonium and other quaternary ammonium compounds in cartilage. , 1971, The Journal of pharmacology and experimental therapeutics.